Vtv Therapeutics Stock Alpha and Beta Analysis
| VTVT Stock | USD 13.91 0.98 7.58% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as vTv Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in VTv Therapeutics over a specified time horizon. Remember, high VTv Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to VTv Therapeutics' market risk premium analysis include:
Beta 0.21 | Alpha 0.14 | Risk 4.21 | Sharpe Ratio 0.032 | Expected Return 0.13 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
VTv |
VTv Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. VTv Therapeutics market risk premium is the additional return an investor will receive from holding VTv Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VTv Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate VTv Therapeutics' performance over market.| α | 0.14 | β | 0.21 |
VTv Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of VTv Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how VTv Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.VTv Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how VTv Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VTv Therapeutics shares will generate the highest return on investment. By understating and applying VTv Therapeutics stock market price indicators, traders can identify VTv Therapeutics position entry and exit signals to maximize returns.
VTv Therapeutics Return and Market Media
The median price of VTv Therapeutics for the period between Thu, Aug 15, 2024 and Wed, Nov 13, 2024 is 14.26 with a coefficient of variation of 6.97. The daily time series for the period is distributed with a sample standard deviation of 1.01, arithmetic mean of 14.42, and mean deviation of 0.79. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | vTv Therapeutics Stock Quotes, Forecast and News Summary - Benzinga | 08/20/2024 |
2 | Discretionary transaction by Al-nahyan Tahnoon Bin Zayed S. of tradable shares of VTv Therapeutics subject to Rule 16b-3 | 09/13/2024 |
3 | vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update | 11/12/2024 |
About VTv Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including VTv or other stocks. Alpha measures the amount that position in vTv Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Inventory Turnover | 0.89 | 6.13 | 7.05 | 6.7 | ROIC | 2.48 | 2.27 | 0.82 | 0.55 |
VTv Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of VTv Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, VTv Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of VTv Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of VTv Therapeutics. Please utilize our Beneish M Score to check the likelihood of VTv Therapeutics' management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with VTv Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.